Ping, Could it be that Dr. Chan is still selling at the market out of the shelf? I don't mind Dr. Chan selling at market as the proceeds will be used to further progress and ultimately add value < dilution. In the quarterly presentations, partnerships are referred to as "potential". With the FDA meetings regarding Refresh2 nearing completion, perhaps Dr. Chan is leaving his options open as far as proceeding with the trial.
News 
Market Data 
Discover 
